Skip to main content
Top
Published in: Journal of Translational Medicine 1/2016

Open Access 01-12-2016 | Review

Microbiota and chronic inflammatory arthritis: an interwoven link

Authors: Andrea Picchianti Diamanti, M. Manuela Rosado, Bruno Laganà, Raffaele D’Amelio

Published in: Journal of Translational Medicine | Issue 1/2016

Login to get access

Abstract

Background

Only recently, the scientific community gained insights on the importance of the intestinal resident flora for the host’s health and disease. Gut microbiota in fact plays a crucial role in modulating innate and acquired immune responses and thus interferes with the fragile balance inflammation versus tolerance.

Main body

Correlations between gut bacteria composition and the severity of inflammation have been studied in inflammatory bowel diseases. More recently similar alterations in the gut microbiota have been reported in patients with spondyloarthritis, whereas in rheumatoid arthritis an accumulating body of evidence evokes a pathogenic role for the altered oral microbiota in disease development and course. In the context of dysbiosis it is also important to remember that different environmental factors like stress, smoke and dietary components can induce strong bacterial changes and consequent exposure of the intestinal epithelium to a variety of different metabolites, many of which have an unknown function. In this perspective, and in complex disorders like autoimmune diseases, not only the genetic makeup, sex and immunologic context of the individual but also the structure of his microbial community should be taken into account.

Conclusions

Here we provide a review of the role of the microbiota in the onset, severity and progression of chronic inflammatory arthritis as well as its impact on the therapeutic management of these patients. Furthermore we point-out the complex interwoven link between gut-joint-brain and immune system by reviewing the most recent data on the literature on the importance of environmental factors such as diet, smoke and stress.
Literature
2.
go back to reference Ergin A, et al. Impaired peripheral Th1 CD4+ T cell response to Escherichia coli proteins in patients with Crohn’s disease and ankylosing spondylitis. J Clin Immunol. 2011;31(6):998–1009.PubMedCrossRef Ergin A, et al. Impaired peripheral Th1 CD4+ T cell response to Escherichia coli proteins in patients with Crohn’s disease and ankylosing spondylitis. J Clin Immunol. 2011;31(6):998–1009.PubMedCrossRef
4.
go back to reference Rhee KJ, et al. Role of commensal bacteria in development of gut-associated lymphoid tissues and preimmune antibody repertoire. J Immunol. 2004;172(2):1118–24.PubMedCrossRef Rhee KJ, et al. Role of commensal bacteria in development of gut-associated lymphoid tissues and preimmune antibody repertoire. J Immunol. 2004;172(2):1118–24.PubMedCrossRef
6.
go back to reference Atarashi K, et al. Treg induction by a rationally selected mixture of clostridia strains from the human microbiota. Nature. 2013;500(7461):232–6.PubMedCrossRef Atarashi K, et al. Treg induction by a rationally selected mixture of clostridia strains from the human microbiota. Nature. 2013;500(7461):232–6.PubMedCrossRef
7.
go back to reference Atarashi K, et al. Induction of colonic regulatory T cells by indigenous clostridium species. Science. 2011;331(6015):337–41.PubMedCrossRef Atarashi K, et al. Induction of colonic regulatory T cells by indigenous clostridium species. Science. 2011;331(6015):337–41.PubMedCrossRef
10.
go back to reference Monach PA, Mathis D, Benoist C. The K/BxN arthritis model. Curr Protoc Immunol. 2008;81:15.22.1–12. Monach PA, Mathis D, Benoist C. The K/BxN arthritis model. Curr Protoc Immunol. 2008;81:15.22.1–12.
11.
go back to reference Block KE, et al. Gut microbiota regulates K/BxN autoimmune arthritis through follicular helper T but not Th17 Cells. J Immunol. 2016;196(4):1550–7.PubMedCrossRef Block KE, et al. Gut microbiota regulates K/BxN autoimmune arthritis through follicular helper T but not Th17 Cells. J Immunol. 2016;196(4):1550–7.PubMedCrossRef
12.
go back to reference Teng F, et al. Gut microbiota drive autoimmune arthritis by promoting differentiation and migration of Peyer’s patch T follicular helper cells. Immunity. 2016;44(4):875–88.PubMedCrossRef Teng F, et al. Gut microbiota drive autoimmune arthritis by promoting differentiation and migration of Peyer’s patch T follicular helper cells. Immunity. 2016;44(4):875–88.PubMedCrossRef
13.
14.
go back to reference Grainger JR, et al. Inflammatory monocytes regulate pathologic responses to commensals during acute gastrointestinal infection. Nat Med. 2013;19(6):713–21.PubMedPubMedCentralCrossRef Grainger JR, et al. Inflammatory monocytes regulate pathologic responses to commensals during acute gastrointestinal infection. Nat Med. 2013;19(6):713–21.PubMedPubMedCentralCrossRef
15.
go back to reference Zhang X, et al. The oral and gut microbiomes are perturbed in rheumatoid arthritis and partly normalized after treatment. Nat Med. 2015;21(8):895–905.PubMedCrossRef Zhang X, et al. The oral and gut microbiomes are perturbed in rheumatoid arthritis and partly normalized after treatment. Nat Med. 2015;21(8):895–905.PubMedCrossRef
16.
go back to reference Kovacs A, et al. Genotype is a stronger determinant than sex of the mouse gut microbiota. Microb Ecol. 2011;61(2):423–8.PubMedCrossRef Kovacs A, et al. Genotype is a stronger determinant than sex of the mouse gut microbiota. Microb Ecol. 2011;61(2):423–8.PubMedCrossRef
17.
go back to reference Rashid T, Ebringer A. Autoimmunity in rheumatic diseases is induced by microbial infections via crossreactivity or molecular mimicry. Autoimmune Dis. 2012;2012:539282.PubMedPubMedCentral Rashid T, Ebringer A. Autoimmunity in rheumatic diseases is induced by microbial infections via crossreactivity or molecular mimicry. Autoimmune Dis. 2012;2012:539282.PubMedPubMedCentral
19.
go back to reference Rosenbaum JT, Davey MP. Time for a gut check: evidence for the hypothesis that HLA-B27 predisposes to ankylosing spondylitis by altering the microbiome. Arthritis Rheum. 2011;63(11):3195–8.PubMedPubMedCentralCrossRef Rosenbaum JT, Davey MP. Time for a gut check: evidence for the hypothesis that HLA-B27 predisposes to ankylosing spondylitis by altering the microbiome. Arthritis Rheum. 2011;63(11):3195–8.PubMedPubMedCentralCrossRef
20.
go back to reference Edwards CJ. Commensal gut bacteria and the etiopathogenesis of rheumatoid arthritis. J Rheumatol. 2008;35(8):1477–97.PubMed Edwards CJ. Commensal gut bacteria and the etiopathogenesis of rheumatoid arthritis. J Rheumatol. 2008;35(8):1477–97.PubMed
21.
go back to reference van der Heijden IM, et al. Presence of bacterial DNA and bacterial peptidoglycans in joints of patients with rheumatoid arthritis and other arthritides. Arthritis Rheum. 2000;43(3):593–8.PubMedCrossRef van der Heijden IM, et al. Presence of bacterial DNA and bacterial peptidoglycans in joints of patients with rheumatoid arthritis and other arthritides. Arthritis Rheum. 2000;43(3):593–8.PubMedCrossRef
22.
go back to reference Rogier R, Koenders MI, Abdollahi-Roodsaz S. Toll-like receptor mediated modulation of T cell response by commensal intestinal microbiota as a trigger for autoimmune arthritis. J Immunol Res. 2015;2015:527696.PubMedPubMedCentralCrossRef Rogier R, Koenders MI, Abdollahi-Roodsaz S. Toll-like receptor mediated modulation of T cell response by commensal intestinal microbiota as a trigger for autoimmune arthritis. J Immunol Res. 2015;2015:527696.PubMedPubMedCentralCrossRef
23.
go back to reference Coenen MJ, et al. Genetic variants in toll-like receptors are not associated with rheumatoid arthritis susceptibility or anti-tumour necrosis factor treatment outcome. PLoS One. 2010;5(12):e14326.PubMedPubMedCentralCrossRef Coenen MJ, et al. Genetic variants in toll-like receptors are not associated with rheumatoid arthritis susceptibility or anti-tumour necrosis factor treatment outcome. PLoS One. 2010;5(12):e14326.PubMedPubMedCentralCrossRef
24.
go back to reference Lee YH, et al. Toll-like receptor polymorphisms and rheumatoid arthritis: a systematic review. Rheumatol Int. 2014;34(1):111–6.PubMedCrossRef Lee YH, et al. Toll-like receptor polymorphisms and rheumatoid arthritis: a systematic review. Rheumatol Int. 2014;34(1):111–6.PubMedCrossRef
25.
go back to reference Cortes A, et al. Identification of multiple risk variants for ankylosing spondylitis through high-density genotyping of immune-related loci. Nat Genet. 2013;45(7):730–8.PubMedPubMedCentralCrossRef Cortes A, et al. Identification of multiple risk variants for ankylosing spondylitis through high-density genotyping of immune-related loci. Nat Genet. 2013;45(7):730–8.PubMedPubMedCentralCrossRef
26.
go back to reference Ma X, et al. Evidence for genetic association of CARD9 and SNAPC4 with ankylosing spondylitis in a Chinese Han population. J Rheumatol. 2014;41(2):318–24.PubMedCrossRef Ma X, et al. Evidence for genetic association of CARD9 and SNAPC4 with ankylosing spondylitis in a Chinese Han population. J Rheumatol. 2014;41(2):318–24.PubMedCrossRef
27.
go back to reference Dean LE, et al. Global prevalence of ankylosing spondylitis. Rheumatology (Oxford). 2014;53(4):650–7.CrossRef Dean LE, et al. Global prevalence of ankylosing spondylitis. Rheumatology (Oxford). 2014;53(4):650–7.CrossRef
28.
go back to reference Mielants H, et al. The evolution of spondyloarthropathies in relation to gut histology. II. Histological aspects. J Rheumatol. 1995;22(12):2273–8.PubMed Mielants H, et al. The evolution of spondyloarthropathies in relation to gut histology. II. Histological aspects. J Rheumatol. 1995;22(12):2273–8.PubMed
29.
30.
31.
go back to reference Sokol H, et al. Low counts of Faecalibacterium prausnitzii in colitis microbiota. Inflamm Bowel Dis. 2009;15(8):1183–9.PubMedCrossRef Sokol H, et al. Low counts of Faecalibacterium prausnitzii in colitis microbiota. Inflamm Bowel Dis. 2009;15(8):1183–9.PubMedCrossRef
32.
go back to reference Sokol H, et al. Specificities of the fecal microbiota in inflammatory bowel disease. Inflamm Bowel Dis. 2006;12(2):106–11.PubMedCrossRef Sokol H, et al. Specificities of the fecal microbiota in inflammatory bowel disease. Inflamm Bowel Dis. 2006;12(2):106–11.PubMedCrossRef
33.
go back to reference Sartor RB, et al. Animal models of intestinal and joint inflammation. Baillieres Clin Rheumatol. 1996;10(1):55–76.PubMedCrossRef Sartor RB, et al. Animal models of intestinal and joint inflammation. Baillieres Clin Rheumatol. 1996;10(1):55–76.PubMedCrossRef
34.
go back to reference Hacquard-Bouder C, Ittah M, Breban M. Animal models of HLA-B27-associated diseases: new outcomes. Joint Bone Spine. 2006;73(2):132–8.PubMedCrossRef Hacquard-Bouder C, Ittah M, Breban M. Animal models of HLA-B27-associated diseases: new outcomes. Joint Bone Spine. 2006;73(2):132–8.PubMedCrossRef
35.
go back to reference Rath HC, et al. Normal luminal bacteria, especially Bacteroides species, mediate chronic colitis, gastritis, and arthritis in HLA-B27/human β2 microglobulin transgenic rats. J Clin Invest. 1996;98(4):945–53.PubMedPubMedCentralCrossRef Rath HC, et al. Normal luminal bacteria, especially Bacteroides species, mediate chronic colitis, gastritis, and arthritis in HLA-B27/human β2 microglobulin transgenic rats. J Clin Invest. 1996;98(4):945–53.PubMedPubMedCentralCrossRef
36.
go back to reference Stebbings S, et al. Comparison of the faecal microflora of patients with ankylosing spondylitis and controls using molecular methods of analysis. Rheumatology (Oxford). 2002;41(12):1395–401.CrossRef Stebbings S, et al. Comparison of the faecal microflora of patients with ankylosing spondylitis and controls using molecular methods of analysis. Rheumatology (Oxford). 2002;41(12):1395–401.CrossRef
37.
go back to reference Stebbings SM, et al. The immune response to autologous bacteroides in ankylosing spondylitis is characterized by reduced interleukin 10 production. J Rheumatol. 2009;36(4):797–800.PubMedCrossRef Stebbings SM, et al. The immune response to autologous bacteroides in ankylosing spondylitis is characterized by reduced interleukin 10 production. J Rheumatol. 2009;36(4):797–800.PubMedCrossRef
38.
go back to reference Stoll ML, et al. Altered microbiota associated with abnormal humoral immune responses to commensal organisms in enthesitis-related arthritis. Arthritis Res Ther. 2014;16(6):486.PubMedPubMedCentralCrossRef Stoll ML, et al. Altered microbiota associated with abnormal humoral immune responses to commensal organisms in enthesitis-related arthritis. Arthritis Res Ther. 2014;16(6):486.PubMedPubMedCentralCrossRef
39.
go back to reference Fahlen A, et al. Comparison of bacterial microbiota in skin biopsies from normal and psoriatic skin. Arch Dermatol Res. 2012;304(1):15–22.PubMedCrossRef Fahlen A, et al. Comparison of bacterial microbiota in skin biopsies from normal and psoriatic skin. Arch Dermatol Res. 2012;304(1):15–22.PubMedCrossRef
40.
go back to reference Gao Z, et al. Experimental study of electroporation-mediated plasmid gene expression in skin and incisional wound. Zhonghua Zheng Xing Wai Ke Za Zhi. 2008;24(5):390–3.PubMed Gao Z, et al. Experimental study of electroporation-mediated plasmid gene expression in skin and incisional wound. Zhonghua Zheng Xing Wai Ke Za Zhi. 2008;24(5):390–3.PubMed
41.
go back to reference Scher JU, et al. Decreased bacterial diversity characterizes the altered gut microbiota in patients with psoriatic arthritis, resembling dysbiosis in inflammatory bowel disease. Arthritis Rheumatol. 2015;67(1):128–39.PubMedPubMedCentralCrossRef Scher JU, et al. Decreased bacterial diversity characterizes the altered gut microbiota in patients with psoriatic arthritis, resembling dysbiosis in inflammatory bowel disease. Arthritis Rheumatol. 2015;67(1):128–39.PubMedPubMedCentralCrossRef
42.
go back to reference Vaahtovuo J, et al. Fecal microbiota in early rheumatoid arthritis. J Rheumatol. 2008;35(8):1500–5.PubMed Vaahtovuo J, et al. Fecal microbiota in early rheumatoid arthritis. J Rheumatol. 2008;35(8):1500–5.PubMed
43.
go back to reference Liu X, et al. Analysis of fecal lactobacillus community structure in patients with early rheumatoid arthritis. Curr Microbiol. 2013;67(2):170–6.PubMedCrossRef Liu X, et al. Analysis of fecal lactobacillus community structure in patients with early rheumatoid arthritis. Curr Microbiol. 2013;67(2):170–6.PubMedCrossRef
46.
go back to reference Maeda Y, et al. Dysbiosis contributes to arthritis development via activation of autoreactive T cells in the intestine. Arthritis Rheumatol. 2016. doi:10.1002/art.39783. Maeda Y, et al. Dysbiosis contributes to arthritis development via activation of autoreactive T cells in the intestine. Arthritis Rheumatol. 2016. doi:10.​1002/​art.​39783.
49.
50.
go back to reference Berthelot JM, et al. Outcome and safety of TNFα antagonist therapy in 475 consecutive outpatients (with rheumatoid arthritis or spondyloarthropathies) treated by a single physician according to their eligibility for clinical trials. Joint Bone Spine. 2010;77(6):564–9.PubMedCrossRef Berthelot JM, et al. Outcome and safety of TNFα antagonist therapy in 475 consecutive outpatients (with rheumatoid arthritis or spondyloarthropathies) treated by a single physician according to their eligibility for clinical trials. Joint Bone Spine. 2010;77(6):564–9.PubMedCrossRef
51.
go back to reference McInnes IB, Schett G. The pathogenesis of rheumatoid arthritis. N Engl J Med. 2011;365(23):2205–19.PubMedCrossRef McInnes IB, Schett G. The pathogenesis of rheumatoid arthritis. N Engl J Med. 2011;365(23):2205–19.PubMedCrossRef
52.
go back to reference Rosenstein ED, et al. Hypothesis: the humoral immune response to oral bacteria provides a stimulus for the development of rheumatoid arthritis. Inflammation. 2004;28(6):311–8.PubMedCrossRef Rosenstein ED, et al. Hypothesis: the humoral immune response to oral bacteria provides a stimulus for the development of rheumatoid arthritis. Inflammation. 2004;28(6):311–8.PubMedCrossRef
53.
go back to reference McGraw WT, et al. Purification, characterization, and sequence analysis of a potential virulence factor from Porphyromonas gingivalis, peptidylarginine deiminase. Infect Immun. 1999;67(7):3248–56.PubMedPubMedCentral McGraw WT, et al. Purification, characterization, and sequence analysis of a potential virulence factor from Porphyromonas gingivalis, peptidylarginine deiminase. Infect Immun. 1999;67(7):3248–56.PubMedPubMedCentral
54.
go back to reference Quirke AM, et al. Heightened immune response to autocitrullinated Porphyromonas gingivalis peptidylarginine deiminase: a potential mechanism for breaching immunologic tolerance in rheumatoid arthritis. Ann Rheum Dis. 2014;73(1):263–9.PubMedCrossRef Quirke AM, et al. Heightened immune response to autocitrullinated Porphyromonas gingivalis peptidylarginine deiminase: a potential mechanism for breaching immunologic tolerance in rheumatoid arthritis. Ann Rheum Dis. 2014;73(1):263–9.PubMedCrossRef
55.
go back to reference Wegner N, et al. Peptidylarginine deiminase from Porphyromonas gingivalis citrullinates human fibrinogen and α-enolase: implications for autoimmunity in rheumatoid arthritis. Arthritis Rheum. 2010;62(9):2662–72.PubMedPubMedCentralCrossRef Wegner N, et al. Peptidylarginine deiminase from Porphyromonas gingivalis citrullinates human fibrinogen and α-enolase: implications for autoimmunity in rheumatoid arthritis. Arthritis Rheum. 2010;62(9):2662–72.PubMedPubMedCentralCrossRef
56.
go back to reference Dissick A, et al. Association of periodontitis with rheumatoid arthritis: a pilot study. J Periodontol. 2010;81(2):223–30.PubMedCrossRef Dissick A, et al. Association of periodontitis with rheumatoid arthritis: a pilot study. J Periodontol. 2010;81(2):223–30.PubMedCrossRef
57.
go back to reference Mercado FB, et al. Relationship between rheumatoid arthritis and periodontitis. J Periodontol. 2001;72(6):779–87.PubMedCrossRef Mercado FB, et al. Relationship between rheumatoid arthritis and periodontitis. J Periodontol. 2001;72(6):779–87.PubMedCrossRef
59.
go back to reference Lange L, et al. Symptoms of periodontitis and antibody responses to Porphyromonas gingivalis in juvenile idiopathic arthritis. Pediatr Rheumatol Online J. 2016;14(1):8.PubMedPubMedCentralCrossRef Lange L, et al. Symptoms of periodontitis and antibody responses to Porphyromonas gingivalis in juvenile idiopathic arthritis. Pediatr Rheumatol Online J. 2016;14(1):8.PubMedPubMedCentralCrossRef
60.
go back to reference Queiroz-Junior CM, et al. Experimental arthritis triggers periodontal disease in mice: involvement of TNF-α and the oral microbiota. J Immunol. 2011;187(7):3821–30.PubMedCrossRef Queiroz-Junior CM, et al. Experimental arthritis triggers periodontal disease in mice: involvement of TNF-α and the oral microbiota. J Immunol. 2011;187(7):3821–30.PubMedCrossRef
61.
go back to reference Ortiz P, et al. Periodontal therapy reduces the severity of active rheumatoid arthritis in patients treated with or without tumor necrosis factor inhibitors. J Periodontol. 2009;80(4):535–40.PubMedPubMedCentralCrossRef Ortiz P, et al. Periodontal therapy reduces the severity of active rheumatoid arthritis in patients treated with or without tumor necrosis factor inhibitors. J Periodontol. 2009;80(4):535–40.PubMedPubMedCentralCrossRef
62.
go back to reference Savioli C, et al. Persistent periodontal disease hampers anti-tumor necrosis factor treatment response in rheumatoid arthritis. J Clin Rheumatol. 2012;18(4):180–4.PubMed Savioli C, et al. Persistent periodontal disease hampers anti-tumor necrosis factor treatment response in rheumatoid arthritis. J Clin Rheumatol. 2012;18(4):180–4.PubMed
63.
go back to reference Salemi S, et al. Could early rheumatoid arthritis resolve after periodontitis treatment only?: case report and review of the literature. Medicine (Baltimore). 2014;93(27):e195.CrossRef Salemi S, et al. Could early rheumatoid arthritis resolve after periodontitis treatment only?: case report and review of the literature. Medicine (Baltimore). 2014;93(27):e195.CrossRef
64.
65.
go back to reference Stolt P, et al. Quantification of the influence of cigarette smoking on rheumatoid arthritis: results from a population based case-control study, using incident cases. Ann Rheum Dis. 2003;62(9):835–41.PubMedPubMedCentralCrossRef Stolt P, et al. Quantification of the influence of cigarette smoking on rheumatoid arthritis: results from a population based case-control study, using incident cases. Ann Rheum Dis. 2003;62(9):835–41.PubMedPubMedCentralCrossRef
66.
go back to reference Majo J, Ghezzo H, Cosio MG. Lymphocyte population and apoptosis in the lungs of smokers and their relation to emphysema. Eur Respir J. 2001;17(5):946–53.PubMedCrossRef Majo J, Ghezzo H, Cosio MG. Lymphocyte population and apoptosis in the lungs of smokers and their relation to emphysema. Eur Respir J. 2001;17(5):946–53.PubMedCrossRef
67.
go back to reference Pryor WA, et al. Fractionation of aqueous cigarette tar extracts: fractions that contain the tar radical cause DNA damage. Chem Res Toxicol. 1998;11(5):441–8.PubMedCrossRef Pryor WA, et al. Fractionation of aqueous cigarette tar extracts: fractions that contain the tar radical cause DNA damage. Chem Res Toxicol. 1998;11(5):441–8.PubMedCrossRef
68.
go back to reference Hughes DA, et al. Numerical and functional alterations in circulatory lymphocytes in cigarette smokers. Clin Exp Immunol. 1985;61(2):459–66.PubMedPubMedCentral Hughes DA, et al. Numerical and functional alterations in circulatory lymphocytes in cigarette smokers. Clin Exp Immunol. 1985;61(2):459–66.PubMedPubMedCentral
69.
go back to reference Tracy RP, et al. Lifetime smoking exposure affects the association of C-reactive protein with cardiovascular disease risk factors and subclinical disease in healthy elderly subjects. Arterioscler Thromb Vasc Biol. 1997;17(10):2167–76.PubMedCrossRef Tracy RP, et al. Lifetime smoking exposure affects the association of C-reactive protein with cardiovascular disease risk factors and subclinical disease in healthy elderly subjects. Arterioscler Thromb Vasc Biol. 1997;17(10):2167–76.PubMedCrossRef
70.
go back to reference Moszczynski P, et al. Immunological findings in cigarette smokers. Toxicol Lett. 2001;118(3):121–7.PubMedCrossRef Moszczynski P, et al. Immunological findings in cigarette smokers. Toxicol Lett. 2001;118(3):121–7.PubMedCrossRef
71.
go back to reference Onozaki K. Etiological and biological aspects of cigarette smoking in rheumatoid arthritis. Inflamm Allerg Drug Targets. 2009;8(5):364–8.CrossRef Onozaki K. Etiological and biological aspects of cigarette smoking in rheumatoid arthritis. Inflamm Allerg Drug Targets. 2009;8(5):364–8.CrossRef
72.
go back to reference Heliovaara M, et al. Smoking and risk of rheumatoid arthritis. J Rheumatol. 1993;20(11):1830–5.PubMed Heliovaara M, et al. Smoking and risk of rheumatoid arthritis. J Rheumatol. 1993;20(11):1830–5.PubMed
73.
go back to reference Karlson EW, et al. Gene-environment interaction between HLA-DRB1 shared epitope and heavy cigarette smoking in predicting incident rheumatoid arthritis. Ann Rheum Dis. 2010;69(1):54–60.PubMedCrossRef Karlson EW, et al. Gene-environment interaction between HLA-DRB1 shared epitope and heavy cigarette smoking in predicting incident rheumatoid arthritis. Ann Rheum Dis. 2010;69(1):54–60.PubMedCrossRef
74.
go back to reference Sugiyama D, et al. Impact of smoking as a risk factor for developing rheumatoid arthritis: a meta-analysis of observational studies. Ann Rheum Dis. 2010;69(1):70–81.PubMedCrossRef Sugiyama D, et al. Impact of smoking as a risk factor for developing rheumatoid arthritis: a meta-analysis of observational studies. Ann Rheum Dis. 2010;69(1):70–81.PubMedCrossRef
75.
go back to reference Ruiz-Esquide V, et al. Anti-citrullinated peptide antibodies in the serum of heavy smokers without rheumatoid arthritis. A differential effect of chronic obstructive pulmonary disease? Clin Rheumatol. 2012;31(7):1047–50.PubMedCrossRef Ruiz-Esquide V, et al. Anti-citrullinated peptide antibodies in the serum of heavy smokers without rheumatoid arthritis. A differential effect of chronic obstructive pulmonary disease? Clin Rheumatol. 2012;31(7):1047–50.PubMedCrossRef
76.
go back to reference Abhishek A, et al. Anti-TNF-α agents are less effective for the treatment of rheumatoid arthritis in current smokers. J Clin Rheumatol. 2010;16(1):15–8.PubMedCrossRef Abhishek A, et al. Anti-TNF-α agents are less effective for the treatment of rheumatoid arthritis in current smokers. J Clin Rheumatol. 2010;16(1):15–8.PubMedCrossRef
77.
go back to reference Hyrich KL, et al. Predictors of response to anti-TNF-α therapy among patients with rheumatoid arthritis: results from the British Society for Rheumatology Biologics Register. Rheumatology (Oxford). 2006;45(12):1558–65.CrossRef Hyrich KL, et al. Predictors of response to anti-TNF-α therapy among patients with rheumatoid arthritis: results from the British Society for Rheumatology Biologics Register. Rheumatology (Oxford). 2006;45(12):1558–65.CrossRef
78.
go back to reference Saevarsdottir S, et al. Patients with early rheumatoid arthritis who smoke are less likely to respond to treatment with methotrexate and tumor necrosis factor inhibitors: observations from the epidemiological investigation of rheumatoid arthritis and the Swedish rheumatology register cohorts. Arthritis Rheum. 2011;63(1):26–36.PubMedCrossRef Saevarsdottir S, et al. Patients with early rheumatoid arthritis who smoke are less likely to respond to treatment with methotrexate and tumor necrosis factor inhibitors: observations from the epidemiological investigation of rheumatoid arthritis and the Swedish rheumatology register cohorts. Arthritis Rheum. 2011;63(1):26–36.PubMedCrossRef
79.
go back to reference Ruiz-Esquide V, Sanmarti R. Tobacco and other environmental risk factors in rheumatoid arthritis. Reumatol Clin. 2012;8(6):342–50.PubMedCrossRef Ruiz-Esquide V, Sanmarti R. Tobacco and other environmental risk factors in rheumatoid arthritis. Reumatol Clin. 2012;8(6):342–50.PubMedCrossRef
81.
go back to reference Zambon JJ, et al. Cigarette smoking increases the risk for subgingival infection with periodontal pathogens. J Periodontol. 1996;67(10 Suppl):1050–4.PubMedCrossRef Zambon JJ, et al. Cigarette smoking increases the risk for subgingival infection with periodontal pathogens. J Periodontol. 1996;67(10 Suppl):1050–4.PubMedCrossRef
82.
83.
go back to reference Lin A, et al. Distinct distal gut microbiome diversity and composition in healthy children from Bangladesh and the United States. PLoS One. 2013;8(1):e53838.PubMedPubMedCentralCrossRef Lin A, et al. Distinct distal gut microbiome diversity and composition in healthy children from Bangladesh and the United States. PLoS One. 2013;8(1):e53838.PubMedPubMedCentralCrossRef
85.
go back to reference Salonen A, de Vos WM. Impact of diet on human intestinal microbiota and health. Annu Rev Food Sci Technol. 2014;5:239–62.PubMedCrossRef Salonen A, de Vos WM. Impact of diet on human intestinal microbiota and health. Annu Rev Food Sci Technol. 2014;5:239–62.PubMedCrossRef
86.
go back to reference De Filippo C, et al. Impact of diet in shaping gut microbiota revealed by a comparative study in children from Europe and rural Africa. Proc Natl Acad Sci USA. 2010;107(33):14691–6.PubMedPubMedCentralCrossRef De Filippo C, et al. Impact of diet in shaping gut microbiota revealed by a comparative study in children from Europe and rural Africa. Proc Natl Acad Sci USA. 2010;107(33):14691–6.PubMedPubMedCentralCrossRef
87.
go back to reference David LA, et al. Diet rapidly and reproducibly alters the human gut microbiome. Nature. 2014;505(7484):559–63.PubMedCrossRef David LA, et al. Diet rapidly and reproducibly alters the human gut microbiome. Nature. 2014;505(7484):559–63.PubMedCrossRef
88.
go back to reference Cotillard A, et al. Dietary intervention impact on gut microbial gene richness. Nature. 2013;500:585–8.PubMedCrossRef Cotillard A, et al. Dietary intervention impact on gut microbial gene richness. Nature. 2013;500:585–8.PubMedCrossRef
89.
go back to reference Hagen KB, et al. Dietary interventions for rheumatoid arthritis. Cochrane Database Syst Rev. 2009;1:CD006400.PubMed Hagen KB, et al. Dietary interventions for rheumatoid arthritis. Cochrane Database Syst Rev. 2009;1:CD006400.PubMed
90.
go back to reference Kjeldsen-Kragh J, et al. Controlled trial of fasting and one-year vegetarian diet in rheumatoid arthritis. Lancet. 1991;338(8772):899–902.PubMedCrossRef Kjeldsen-Kragh J, et al. Controlled trial of fasting and one-year vegetarian diet in rheumatoid arthritis. Lancet. 1991;338(8772):899–902.PubMedCrossRef
91.
go back to reference Skoldstam L, Hagfors L, Johansson G. An experimental study of a Mediterranean diet intervention for patients with rheumatoid arthritis. Ann Rheum Dis. 2003;62(3):208–14.PubMedPubMedCentralCrossRef Skoldstam L, Hagfors L, Johansson G. An experimental study of a Mediterranean diet intervention for patients with rheumatoid arthritis. Ann Rheum Dis. 2003;62(3):208–14.PubMedPubMedCentralCrossRef
92.
go back to reference Holst-Jensen SE, et al. Treatment of rheumatoid arthritis with a peptide diet: a randomized, controlled trial. Scand J Rheumatol. 1998;27(5):329–36.PubMedCrossRef Holst-Jensen SE, et al. Treatment of rheumatoid arthritis with a peptide diet: a randomized, controlled trial. Scand J Rheumatol. 1998;27(5):329–36.PubMedCrossRef
93.
go back to reference Kavanaghi R, et al. The effects of elemental diet and subsequent food reintroduction on rheumatoid arthritis. Br J Rheumatol. 1995;34(3):270–3.PubMedCrossRef Kavanaghi R, et al. The effects of elemental diet and subsequent food reintroduction on rheumatoid arthritis. Br J Rheumatol. 1995;34(3):270–3.PubMedCrossRef
94.
go back to reference Calder PC, Deckelbaum RJ. Omega-3 fatty acids: time to get the messages right! Curr Opin Clin Nutr Metab Care. 2008;11(2):91–3.PubMedCrossRef Calder PC, Deckelbaum RJ. Omega-3 fatty acids: time to get the messages right! Curr Opin Clin Nutr Metab Care. 2008;11(2):91–3.PubMedCrossRef
95.
go back to reference Miles EA, Calder PC. Influence of marine n-3 polyunsaturated fatty acids on immune function and a systematic review of their effects on clinical outcomes in rheumatoid arthritis. Br J Nutr. 2012;107(Suppl 2):S171–84.PubMedCrossRef Miles EA, Calder PC. Influence of marine n-3 polyunsaturated fatty acids on immune function and a systematic review of their effects on clinical outcomes in rheumatoid arthritis. Br J Nutr. 2012;107(Suppl 2):S171–84.PubMedCrossRef
96.
go back to reference De Caterina R, et al. The omega-3 fatty acid docosahexaenoate reduces cytokine-induced expression of proatherogenic and proinflammatory proteins in human endothelial cells. Arterioscler Thromb. 1994;14(11):1829–36.PubMedCrossRef De Caterina R, et al. The omega-3 fatty acid docosahexaenoate reduces cytokine-induced expression of proatherogenic and proinflammatory proteins in human endothelial cells. Arterioscler Thromb. 1994;14(11):1829–36.PubMedCrossRef
97.
go back to reference Kolahi S, et al. Fish oil supplementation decreases serum soluble receptor activator of nuclear factor-kappa B ligand/osteoprotegerin ratio in female patients with rheumatoid arthritis. Clin Biochem. 2010;43(6):576–80.PubMedCrossRef Kolahi S, et al. Fish oil supplementation decreases serum soluble receptor activator of nuclear factor-kappa B ligand/osteoprotegerin ratio in female patients with rheumatoid arthritis. Clin Biochem. 2010;43(6):576–80.PubMedCrossRef
98.
go back to reference Lo CJ, et al. Fish oil augments macrophage cyclooxygenase II (COX-2) gene expression induced by endotoxin. J Surg Res. 1999;86(1):103–7.PubMedCrossRef Lo CJ, et al. Fish oil augments macrophage cyclooxygenase II (COX-2) gene expression induced by endotoxin. J Surg Res. 1999;86(1):103–7.PubMedCrossRef
99.
go back to reference Lo CJ, et al. Fish oil decreases macrophage tumor necrosis factor gene transcription by altering the NF κ B activity. J Surg Res. 1999;82(2):216–21.PubMedCrossRef Lo CJ, et al. Fish oil decreases macrophage tumor necrosis factor gene transcription by altering the NF κ B activity. J Surg Res. 1999;82(2):216–21.PubMedCrossRef
100.
go back to reference Trebble T, et al. Inhibition of tumour necrosis factor-α and interleukin 6 production by mononuclear cells following dietary fish-oil supplementation in healthy men and response to antioxidant co-supplementation. Br J Nutr. 2003;90(2):405–12.PubMedCrossRef Trebble T, et al. Inhibition of tumour necrosis factor-α and interleukin 6 production by mononuclear cells following dietary fish-oil supplementation in healthy men and response to antioxidant co-supplementation. Br J Nutr. 2003;90(2):405–12.PubMedCrossRef
101.
102.
go back to reference Leslie CA, et al. Dietary fish oil modulates macrophage fatty acids and decreases arthritis susceptibility in mice. J Exp Med. 1985;162(4):1336–49.PubMedCrossRef Leslie CA, et al. Dietary fish oil modulates macrophage fatty acids and decreases arthritis susceptibility in mice. J Exp Med. 1985;162(4):1336–49.PubMedCrossRef
103.
go back to reference Canning MO, et al. 1-α,25-Dihydroxyvitamin D3 (1,25(OH)(2)D(3)) hampers the maturation of fully active immature dendritic cells from monocytes. Eur J Endocrinol. 2001;145(3):351–7.PubMedCrossRef Canning MO, et al. 1-α,25-Dihydroxyvitamin D3 (1,25(OH)(2)D(3)) hampers the maturation of fully active immature dendritic cells from monocytes. Eur J Endocrinol. 2001;145(3):351–7.PubMedCrossRef
104.
go back to reference Cantorna MT, Hayes CE, DeLuca HF. 1,25-Dihydroxycholecalciferol inhibits the progression of arthritis in murine models of human arthritis. J Nutr. 1998;128(1):68–72.PubMed Cantorna MT, Hayes CE, DeLuca HF. 1,25-Dihydroxycholecalciferol inhibits the progression of arthritis in murine models of human arthritis. J Nutr. 1998;128(1):68–72.PubMed
105.
go back to reference Feser M, et al. Plasma 25, OH vitamin D concentrations are not associated with rheumatoid arthritis (RA)-related autoantibodies in individuals at elevated risk for RA. J Rheumatol. 2009;36(5):943–6.PubMedPubMedCentralCrossRef Feser M, et al. Plasma 25, OH vitamin D concentrations are not associated with rheumatoid arthritis (RA)-related autoantibodies in individuals at elevated risk for RA. J Rheumatol. 2009;36(5):943–6.PubMedPubMedCentralCrossRef
106.
go back to reference Patel S, et al. Association between serum vitamin D metabolite levels and disease activity in patients with early inflammatory polyarthritis. Arthritis Rheum. 2007;56(7):2143–9.PubMedCrossRef Patel S, et al. Association between serum vitamin D metabolite levels and disease activity in patients with early inflammatory polyarthritis. Arthritis Rheum. 2007;56(7):2143–9.PubMedCrossRef
107.
108.
go back to reference Selye H. A syndrome produced by diverse nocuous agents. Nature. 1936;138:32.CrossRef Selye H. A syndrome produced by diverse nocuous agents. Nature. 1936;138:32.CrossRef
109.
go back to reference Dobbin JP, et al. Cytokine production and lymphocyte transformation during stress. Brain Behav Immun. 1991;5(4):339–48.PubMedCrossRef Dobbin JP, et al. Cytokine production and lymphocyte transformation during stress. Brain Behav Immun. 1991;5(4):339–48.PubMedCrossRef
110.
go back to reference Kiecolt-Glaser JK, et al. Psychosocial modifiers of immunocompetence in medical students. Psychosom Med. 1984;46(1):7–14.PubMedCrossRef Kiecolt-Glaser JK, et al. Psychosocial modifiers of immunocompetence in medical students. Psychosom Med. 1984;46(1):7–14.PubMedCrossRef
111.
go back to reference Lupien SJ, et al. Effects of stress throughout the lifespan on the brain, behaviour and cognition. Nat Rev Neurosci. 2009;10(6):434–45.PubMedCrossRef Lupien SJ, et al. Effects of stress throughout the lifespan on the brain, behaviour and cognition. Nat Rev Neurosci. 2009;10(6):434–45.PubMedCrossRef
112.
go back to reference McCray CJ, Agarwal SK. Stress and autoimmunity. Immunol Allerg Clin North Am. 2011;31(1):1–18.CrossRef McCray CJ, Agarwal SK. Stress and autoimmunity. Immunol Allerg Clin North Am. 2011;31(1):1–18.CrossRef
113.
go back to reference Segerstrom SC, Miller GE. Psychological stress and the human immune system: a meta-analytic study of 30 years of inquiry. Psychol Bull. 2004;130(4):601–30.PubMedPubMedCentralCrossRef Segerstrom SC, Miller GE. Psychological stress and the human immune system: a meta-analytic study of 30 years of inquiry. Psychol Bull. 2004;130(4):601–30.PubMedPubMedCentralCrossRef
114.
go back to reference Freier E, et al. Decrease of CD4(+)FOXP3(+) T regulatory cells in the peripheral blood of human subjects undergoing a mental stressor. Psychoneuroendocrinology. 2010;35(5):663–73.PubMedCrossRef Freier E, et al. Decrease of CD4(+)FOXP3(+) T regulatory cells in the peripheral blood of human subjects undergoing a mental stressor. Psychoneuroendocrinology. 2010;35(5):663–73.PubMedCrossRef
115.
go back to reference Pedersen AF, Zachariae R, Bovbjerg DH. Psychological stress and antibody response to influenza vaccination: a meta-analysis. Brain Behav Immun. 2009;23(4):427–33.PubMedCrossRef Pedersen AF, Zachariae R, Bovbjerg DH. Psychological stress and antibody response to influenza vaccination: a meta-analysis. Brain Behav Immun. 2009;23(4):427–33.PubMedCrossRef
116.
go back to reference Herrmann M, Scholmerich J, Straub RH. Stress and rheumatic diseases. Rheum Dis Clin North Am. 2000;26(4):737–63.PubMedCrossRef Herrmann M, Scholmerich J, Straub RH. Stress and rheumatic diseases. Rheum Dis Clin North Am. 2000;26(4):737–63.PubMedCrossRef
117.
go back to reference Persson LO, Berglund K, Sahlberg D. Psychological factors in chronic rheumatic diseases—a review. The case of rheumatoid arthritis, current research and some problems. Scand J Rheumatol. 1999;28(3):137–44.PubMedCrossRef Persson LO, Berglund K, Sahlberg D. Psychological factors in chronic rheumatic diseases—a review. The case of rheumatoid arthritis, current research and some problems. Scand J Rheumatol. 1999;28(3):137–44.PubMedCrossRef
118.
go back to reference Wolfe F, Pincus T. Listening to the patient: a practical guide to self-report questionnaires in clinical care. Arthritis Rheum. 1999;42(9):1797–808.PubMedCrossRef Wolfe F, Pincus T. Listening to the patient: a practical guide to self-report questionnaires in clinical care. Arthritis Rheum. 1999;42(9):1797–808.PubMedCrossRef
119.
go back to reference Dekkers JC, et al. Biopsychosocial mediators and moderators of stress-health relationships in patients with recently diagnosed rheumatoid arthritis. Arthritis Rheum. 2001;45(4):307–16.PubMedCrossRef Dekkers JC, et al. Biopsychosocial mediators and moderators of stress-health relationships in patients with recently diagnosed rheumatoid arthritis. Arthritis Rheum. 2001;45(4):307–16.PubMedCrossRef
120.
go back to reference Jacobs R, et al. Systemic lupus erythematosus and rheumatoid arthritis patients differ from healthy controls in their cytokine pattern after stress exposure. Rheumatology (Oxford). 2001;40(8):868–75.CrossRef Jacobs R, et al. Systemic lupus erythematosus and rheumatoid arthritis patients differ from healthy controls in their cytokine pattern after stress exposure. Rheumatology (Oxford). 2001;40(8):868–75.CrossRef
121.
go back to reference van der Voort CR, et al. Noradrenaline induces phosphorylation of ERK-2 in human peripheral blood mononuclear cells after induction of α(1)-adrenergic receptors. J Neuroimmunol. 2000;108(1–2):82–91.CrossRef van der Voort CR, et al. Noradrenaline induces phosphorylation of ERK-2 in human peripheral blood mononuclear cells after induction of α(1)-adrenergic receptors. J Neuroimmunol. 2000;108(1–2):82–91.CrossRef
122.
go back to reference Conway SC, Creed FH, Symmons DP. Life events and the onset of rheumatoid arthritis. J Psychosom Res. 1994;38(8):837–47.PubMedCrossRef Conway SC, Creed FH, Symmons DP. Life events and the onset of rheumatoid arthritis. J Psychosom Res. 1994;38(8):837–47.PubMedCrossRef
123.
go back to reference Kopec JA, Sayre EC. Traumatic experiences in childhood and the risk of arthritis: a prospective cohort study. Can J Public Health. 2004;95(5):361–5.PubMed Kopec JA, Sayre EC. Traumatic experiences in childhood and the risk of arthritis: a prospective cohort study. Can J Public Health. 2004;95(5):361–5.PubMed
124.
go back to reference Thomason BT, et al. The relation between stress and disease activity in rheumatoid arthritis. J Behav Med. 1992;15(2):215–20.PubMedCrossRef Thomason BT, et al. The relation between stress and disease activity in rheumatoid arthritis. J Behav Med. 1992;15(2):215–20.PubMedCrossRef
125.
go back to reference Zautra AJ, et al. Daily fatigue in women with osteoarthritis, rheumatoid arthritis, and fibromyalgia. Pain. 2007;128(1–2):128–35.PubMedCrossRef Zautra AJ, et al. Daily fatigue in women with osteoarthritis, rheumatoid arthritis, and fibromyalgia. Pain. 2007;128(1–2):128–35.PubMedCrossRef
126.
go back to reference Potter PT, et al. Interpersonal workplace stressors and well-being: a multi-wave study of employees with and without arthritis. J Appl Psychol. 2002;87(4):789–96.PubMedCrossRef Potter PT, et al. Interpersonal workplace stressors and well-being: a multi-wave study of employees with and without arthritis. J Appl Psychol. 2002;87(4):789–96.PubMedCrossRef
127.
go back to reference Neufeld KM, et al. Reduced anxiety-like behavior and central neurochemical change in germ-free mice. Neurogastroenterol Motil. 2011;23(3):255–64.CrossRefPubMed Neufeld KM, et al. Reduced anxiety-like behavior and central neurochemical change in germ-free mice. Neurogastroenterol Motil. 2011;23(3):255–64.CrossRefPubMed
128.
go back to reference Nishino R, et al. Commensal microbiota modulate murine behaviors in a strictly contamination-free environment confirmed by culture-based methods. Neurogastroenterol Motil. 2013;25(6):521–8.PubMedCrossRef Nishino R, et al. Commensal microbiota modulate murine behaviors in a strictly contamination-free environment confirmed by culture-based methods. Neurogastroenterol Motil. 2013;25(6):521–8.PubMedCrossRef
129.
130.
go back to reference Topol IA, et al. Expression of XBP1 in lymphocytes of the small intestine in rats under chronic social stress and modulation of intestinal microflora composition. Fiziol Zh. 2014;60(2):38–44.PubMed Topol IA, et al. Expression of XBP1 in lymphocytes of the small intestine in rats under chronic social stress and modulation of intestinal microflora composition. Fiziol Zh. 2014;60(2):38–44.PubMed
131.
go back to reference Naseribafrouei A, et al. Correlation between the human fecal microbiota and depression. Neurogastroenterol Motil. 2014;26(8):1155–62.PubMedCrossRef Naseribafrouei A, et al. Correlation between the human fecal microbiota and depression. Neurogastroenterol Motil. 2014;26(8):1155–62.PubMedCrossRef
132.
go back to reference Jeffery IB, et al. An irritable bowel syndrome subtype defined by species-specific alterations in faecal microbiota. Gut. 2012;61(7):997–1006.PubMedCrossRef Jeffery IB, et al. An irritable bowel syndrome subtype defined by species-specific alterations in faecal microbiota. Gut. 2012;61(7):997–1006.PubMedCrossRef
133.
go back to reference Lee KJ, Tack J. Altered intestinal microbiota in irritable bowel syndrome. Neurogastroenterol Motil. 2010;22(5):493–8.PubMedCrossRef Lee KJ, Tack J. Altered intestinal microbiota in irritable bowel syndrome. Neurogastroenterol Motil. 2010;22(5):493–8.PubMedCrossRef
134.
go back to reference Tana C, et al. Altered profiles of intestinal microbiota and organic acids may be the origin of symptoms in irritable bowel syndrome. Neurogastroenterol Motil. 2010;22(5):512–9.PubMed Tana C, et al. Altered profiles of intestinal microbiota and organic acids may be the origin of symptoms in irritable bowel syndrome. Neurogastroenterol Motil. 2010;22(5):512–9.PubMed
135.
go back to reference D’Mello C, et al. Probiotics improve inflammation-associated sickness behavior by altering communication between the peripheral immune system and the brain. J Neurosci. 2015;35(30):10821–30.PubMedCrossRef D’Mello C, et al. Probiotics improve inflammation-associated sickness behavior by altering communication between the peripheral immune system and the brain. J Neurosci. 2015;35(30):10821–30.PubMedCrossRef
138.
go back to reference So JS, et al. Lactobacillus casei suppresses experimental arthritis by down-regulating T helper 1 effector functions. Mol Immunol. 2008;45(9):2690–9.PubMedCrossRef So JS, et al. Lactobacillus casei suppresses experimental arthritis by down-regulating T helper 1 effector functions. Mol Immunol. 2008;45(9):2690–9.PubMedCrossRef
139.
go back to reference So JS, et al. Lactobacillus casei potentiates induction of oral tolerance in experimental arthritis. Mol Immunol. 2008;46(1):172–80.PubMedCrossRef So JS, et al. Lactobacillus casei potentiates induction of oral tolerance in experimental arthritis. Mol Immunol. 2008;46(1):172–80.PubMedCrossRef
140.
go back to reference Amdekar S, et al. Lactobacillus casei reduces the inflammatory joint damage associated with collagen-induced arthritis (CIA) by reducing the pro-inflammatory cytokines: Lactobacillus casei: COX-2 inhibitor. J Clin Immunol. 2011;31(2):147–54.PubMedCrossRef Amdekar S, et al. Lactobacillus casei reduces the inflammatory joint damage associated with collagen-induced arthritis (CIA) by reducing the pro-inflammatory cytokines: Lactobacillus casei: COX-2 inhibitor. J Clin Immunol. 2011;31(2):147–54.PubMedCrossRef
141.
go back to reference Mandel DR, Eichas K, Holmes J. Bacillus coagulans: a viable adjunct therapy for relieving symptoms of rheumatoid arthritis according to a randomized, controlled trial. BMC Complement Altern Med. 2010;10:1.PubMedPubMedCentralCrossRef Mandel DR, Eichas K, Holmes J. Bacillus coagulans: a viable adjunct therapy for relieving symptoms of rheumatoid arthritis according to a randomized, controlled trial. BMC Complement Altern Med. 2010;10:1.PubMedPubMedCentralCrossRef
142.
go back to reference Pineda Mde L, et al. A randomized, double-blinded, placebo-controlled pilot study of probiotics in active rheumatoid arthritis. Med Sci Monit. 2011;17(6):CR347–54.PubMed Pineda Mde L, et al. A randomized, double-blinded, placebo-controlled pilot study of probiotics in active rheumatoid arthritis. Med Sci Monit. 2011;17(6):CR347–54.PubMed
143.
go back to reference Vaghef-Mehrabany E, et al. Probiotic supplementation improves inflammatory status in patients with rheumatoid arthritis. Nutrition. 2014;30(4):430–5.PubMedCrossRef Vaghef-Mehrabany E, et al. Probiotic supplementation improves inflammatory status in patients with rheumatoid arthritis. Nutrition. 2014;30(4):430–5.PubMedCrossRef
144.
go back to reference Sanges M, et al. Probiotics in spondyloarthropathy associated with ulcerative colitis: a pilot study. Eur Rev Med Pharmacol Sci. 2009;13(3):233–4.PubMed Sanges M, et al. Probiotics in spondyloarthropathy associated with ulcerative colitis: a pilot study. Eur Rev Med Pharmacol Sci. 2009;13(3):233–4.PubMed
145.
go back to reference Jenks K, et al. Probiotic therapy for the treatment of spondyloarthritis: a randomized controlled trial. J Rheumatol. 2010;37(10):2118–25.PubMedCrossRef Jenks K, et al. Probiotic therapy for the treatment of spondyloarthritis: a randomized controlled trial. J Rheumatol. 2010;37(10):2118–25.PubMedCrossRef
146.
go back to reference Berntson L, Hedlund-Treutiger I, Alving K. Anti-inflammatory effect of exclusive enteral nutrition in patients with juvenile idiopathic arthritis. Clin Exp Rheumatol. 2016 [Epub ahead of print]. Berntson L, Hedlund-Treutiger I, Alving K. Anti-inflammatory effect of exclusive enteral nutrition in patients with juvenile idiopathic arthritis. Clin Exp Rheumatol. 2016 [Epub ahead of print].
148.
go back to reference Iida N, et al. Commensal bacteria control cancer response to therapy by modulating the tumor microenvironment. Science. 2013;342(6161):967–70.PubMedCrossRef Iida N, et al. Commensal bacteria control cancer response to therapy by modulating the tumor microenvironment. Science. 2013;342(6161):967–70.PubMedCrossRef
150.
go back to reference Das KM, et al. The metabolism of salicylazosulfapyridine in ulcerative colitis. I. The relationship between metabolites and the response to treatment in inpatients. Gut. 1973;14(8):631–41.PubMedPubMedCentralCrossRef Das KM, et al. The metabolism of salicylazosulfapyridine in ulcerative colitis. I. The relationship between metabolites and the response to treatment in inpatients. Gut. 1973;14(8):631–41.PubMedPubMedCentralCrossRef
151.
go back to reference Peppercorn MA, Goldman P. The role of intestinal bacteria in the metabolism of salicylazosulfapyridine. J Pharmacol Exp Ther. 1972;181(3):555–62.PubMed Peppercorn MA, Goldman P. The role of intestinal bacteria in the metabolism of salicylazosulfapyridine. J Pharmacol Exp Ther. 1972;181(3):555–62.PubMed
152.
go back to reference Lee HJ, et al. The effects of an orally administered probiotic on sulfasalazine metabolism in individuals with rheumatoid arthritis: a preliminary study. Int J Rheum Dis. 2010;13(1):48–54.PubMedCrossRef Lee HJ, et al. The effects of an orally administered probiotic on sulfasalazine metabolism in individuals with rheumatoid arthritis: a preliminary study. Int J Rheum Dis. 2010;13(1):48–54.PubMedCrossRef
153.
go back to reference Rajca S, et al. Alterations in the intestinal microbiome (dysbiosis) as a predictor of relapse after infliximab withdrawal in Crohn’s disease. Inflamm Bowel Dis. 2014;20(6):978–86.PubMed Rajca S, et al. Alterations in the intestinal microbiome (dysbiosis) as a predictor of relapse after infliximab withdrawal in Crohn’s disease. Inflamm Bowel Dis. 2014;20(6):978–86.PubMed
Metadata
Title
Microbiota and chronic inflammatory arthritis: an interwoven link
Authors
Andrea Picchianti Diamanti
M. Manuela Rosado
Bruno Laganà
Raffaele D’Amelio
Publication date
01-12-2016
Publisher
BioMed Central
Published in
Journal of Translational Medicine / Issue 1/2016
Electronic ISSN: 1479-5876
DOI
https://doi.org/10.1186/s12967-016-0989-3

Other articles of this Issue 1/2016

Journal of Translational Medicine 1/2016 Go to the issue
Obesity Clinical Trial Summary

At a glance: The STEP trials

A round-up of the STEP phase 3 clinical trials evaluating semaglutide for weight loss in people with overweight or obesity.

Developed by: Springer Medicine

Highlights from the ACC 2024 Congress

Year in Review: Pediatric cardiology

Watch Dr. Anne Marie Valente present the last year's highlights in pediatric and congenital heart disease in the official ACC.24 Year in Review session.

Year in Review: Pulmonary vascular disease

The last year's highlights in pulmonary vascular disease are presented by Dr. Jane Leopold in this official video from ACC.24.

Year in Review: Valvular heart disease

Watch Prof. William Zoghbi present the last year's highlights in valvular heart disease from the official ACC.24 Year in Review session.

Year in Review: Heart failure and cardiomyopathies

Watch this official video from ACC.24. Dr. Biykem Bozkurt discusses last year's major advances in heart failure and cardiomyopathies.